Literature DB >> 27578021

Bilirubin-induced ER stress contributes to the inflammatory response and apoptosis in neuronal cells.

Mohammed Qaisiya1, Cristina Brischetto2, Jana Jašprová3, Libor Vitek3,4, Claudio Tiribelli2,5, Cristina Bellarosa2.   

Abstract

Unconjugated bilirubin (UCB) in newborns may lead to bilirubin neurotoxicity. Few studies investigated the activation of endoplasmic reticulum stress (ER stress) by UCB. We performed an in vitro comparative study using undifferentiated SH-SY5Y, differentiated GI-ME-N neuronal cells and human U87 astrocytoma cells. ER stress and its contribution to inflammation and apoptosis induced by UCB were analyzed. Cytotoxicity, ER stress and inflammation were observed only in neuronal cells, despite intracellular UCB accumulation in all three cell types. UCB toxicity was enhanced in undifferentiated SH-SY5Y cells and correlated with a higher mRNA expression of pro-apoptotic CHOP. Mouse embryonic fibroblast knockout for CHOP and CHOP siRNA-silenced SH-SY5Y increased cells viability upon UCB exposure. In SH-SY5Y, ER stress inhibition by 4-phenylbutyric acid reduced UCB-induced apoptosis and decreased the cleaved forms of caspase-3 and PARP proteins. Reporter gene assay and PERK siRNA showed that IL-8 induction by UCB is transcriptionally regulated by NFкB and PERK signaling. These data suggest that ER stress has an important role in the UCB-induced inflammation and apoptosis, and that targeting ER stress may represent a potential therapeutic approach to decrease UCB-induced neurotoxicity.

Entities:  

Keywords:  4-PBA; Bilirubin neurotoxicity; CHOP; ER stress; NFкB

Mesh:

Substances:

Year:  2016        PMID: 27578021     DOI: 10.1007/s00204-016-1835-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  8 in total

1.  Palmitic acid induces human osteoblast-like Saos-2 cell apoptosis via endoplasmic reticulum stress and autophagy.

Authors:  Lei Yang; Gaopeng Guan; Lanjie Lei; Qizhuang Lv; Shengyuan Liu; Xiuwen Zhan; Zhenzhen Jiang; Xiang Gu
Journal:  Cell Stress Chaperones       Date:  2018-09-07       Impact factor: 3.667

2.  Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1 -/- mouse model.

Authors:  Simone Vodret; Giulia Bortolussi; Jana Jašprová; Libor Vitek; Andrés F Muro
Journal:  J Neuroinflammation       Date:  2017-03-24       Impact factor: 8.322

3.  Manganese activates autophagy to alleviate endoplasmic reticulum stress-induced apoptosis via PERK pathway.

Authors:  Chang Liu; Dong-Ying Yan; Can Wang; Zhuo Ma; Yu Deng; Wei Liu; Bin Xu
Journal:  J Cell Mol Med       Date:  2019-10-22       Impact factor: 5.310

Review 4.  Extracellular Vesicles in CNS Developmental Disorders.

Authors:  Ana Rita Gomes; Nasim Bahram Sangani; Tiago G Fernandes; M Margarida Diogo; Leopold M G Curfs; Chris P Reutelingsperger
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

5.  Comprehensive metabolomics study on the pathogenesis of anaplastic astrocytoma via UPLC-Q/TOF-MS.

Authors:  Chao Du; Zhehao Huang; Bo Wei; Miao Li
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

Review 6.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

7.  Glutathione S-Transferase P1 Protects Against Amodiaquine Quinoneimines-Induced Cytotoxicity but Does Not Prevent Activation of Endoplasmic Reticulum Stress in HepG2 Cells.

Authors:  Yongjie Zhang; Shalenie P den Braver-Sewradj; Michiel W den Braver; Steven Hiemstra; Nico P E Vermeulen; Bob van de Water; Jan N M Commandeur; J C Vos
Journal:  Front Pharmacol       Date:  2018-04-18       Impact factor: 5.810

8.  Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy.

Authors:  Ning Tan; Shuiwang Hu; Zhen Hu; Zhouli Wu; Bin Wang
Journal:  Mol Med Rep       Date:  2020-05-28       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.